When considering the variability of drug metabolism among different geographical ancestries, which factor is most relevant for optimizing patient-specific therapy?

Question

BlackTom AI · Accepted Answer

When assessing how genetic differences across populations influence drug metabolism, we need to focus on the genetic factors that drive enzymatic activity directly. 
Option 1: Recognizing the prevalence of specific enzyme polymorphisms for appropriate dose individualization. This is the key factor, because genetic variations (polymorphisms) in drug-metabolizing enzymes (like CYP450 isoforms) can change how quickly or slowly a drug is processed, guiding personalized dosing strategies. Emphasizing these polymorphisms supports optimization of therapy on an individual basis across ancestries.
Option 2: Considering the patient’s location as the sole determinant. While geography can be a proxy for ancestry, relying on location alone is insufficient and potentially misleading, since within-population genetic diversity exists and not all metabolic differences align neatly with geography. This option overgeneralizes and ignores direct genetic data.
Option 3: Focusing on dietary habits exclusive to the region. Diet can modulate enzyme activity to some extent, but it does not capture the primary source of interindividual and interethnic variability in drug metabolism, which is largely driven by genetic polymorphisms rather than regional cuisine alone.
Option 4: Using a uniform dosing strategy regardless of genetic background. This approach neglects known pharmacogenetic differences, risking underdosing or toxicity in individuals with particular polymorphisms. It ignores the very mechanism by which metabolism varies across ancestries and fails to promote personalization.
Overall, the most relevant factor for optimizing patient-specific therapy in the context of metabolic variability is the distribution of enzyme polymorphisms, as they directly influence drug clearance and dosing requirements across populations.

PCOL2021 2025 Practice MCQ Section A - 2025

When considering the variability of drug metabolism among different geographical ancestries, which factor is most relevant for optimizing patient-specific therapy?

查看解析

登录即可查看完整答案

类似问题

Evaluate the implications of pharmacogenomic variations in metabolizing enzymes when designing a clinical trial for a new cardiovascular drug.

How can genetic variation in HLA antigens influence drug therapy outcomes?

In evaluating a patient’s CYP2D6 phenotype before prescribing a drug with a narrow therapeutic window, which of the following represents the most critical clinical concerns?

Which factor is NOT typically influenced by genetic variations in pharmacogenomics?

Evaluate the importance of integrating pharmacogenomic considerations into global drug development strategies.

What role do drug transporters play in pharmacogenomics?

In a consumer society, many adults channel creativity into buying things

更多留学生实用工具

考试浏览器助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单